Health Catalyst Q1 2025 Revenue Soars
Ticker: HCAT · Form: 10-Q · Filed: May 9, 2025 · CIK: 1636422
| Field | Detail |
|---|---|
| Company | Health Catalyst, Inc. (HCAT) |
| Form Type | 10-Q |
| Filed Date | May 9, 2025 |
| Risk Level | medium |
| Sentiment | mixed |
Sentiment: mixed
Topics: earnings, revenue-growth, financials
TL;DR
**Health Catalyst Q1 revenue jumps from $395 to $1.5M!**
AI Summary
Health Catalyst, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported revenue of $1,502,590 for the first quarter of 2025, a significant increase from $395 in the same period of 2024. The filing details financial performance across its Technology and Professional Services segments.
Why It Matters
This filing provides insight into Health Catalyst's financial performance and revenue growth trajectory in early 2025, which could impact investor confidence and market valuation.
Risk Assessment
Risk Level: medium — The significant revenue jump from a very low base in the prior year warrants scrutiny to understand the sustainability and drivers of this growth.
Key Numbers
- $1.50M — Q1 2025 Revenue (Represents a substantial increase from the prior year's Q1.)
- $395 — Q1 2024 Revenue (The baseline revenue for comparison in the current period.)
Key Players & Entities
- Health Catalyst, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- $1,502,590 (dollar_amount) — Revenue for Q1 2025
- $395 (dollar_amount) — Revenue for Q1 2024
FAQ
What is the primary driver behind the significant revenue increase from $395 in Q1 2024 to $1,502,590 in Q1 2025?
The filing indicates revenue growth across segments, but specific drivers for this magnitude of increase are not detailed in the provided snippet.
How does Health Catalyst define its 'Technology' and 'Professional Services' segments?
The filing mentions these segments (hcat:TechnologyMember, hcat:ProfessionalServicesMember) but does not provide definitions in the excerpt.
What is the company's net income or loss for the quarter ending March 31, 2025?
Net income/loss figures are not present in the provided excerpt of the 10-Q.
What was the total number of shares outstanding as of March 31, 2025?
The filing mentions 'xbrli:shares' and specific dates, but the exact number of shares outstanding for March 31, 2025, is not explicitly stated in this snippet.
Are there any significant changes in the company's debt or equity structure reported in this filing?
The filing references equity components like 'us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember' and 'us-gaap:RetainedEarningsMember' for both 2024 and 2025, but details on debt changes are not in the provided text.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 9, 2025 regarding Health Catalyst, Inc. (HCAT).